Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Emerich

Showing results (1-10 of 103) with videos related to

Pageof 11
Sort By:
Cell Transplantation|July 4, 2002
Cell transplantation for Parkinson's diseaseD F Emerich
Trends in Neurosciences|June 6, 2000
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?D F Emerich
Cell Transplantation|September 5, 2017
Article Commentary: Cell Transplantation for Parkinson's DiseaseD F Emerich
Cell Transplantation|March 4, 2000
Encapsulated CNTF-producing cells for Huntington's diseaseD F Emerich
Journal of Neural Transplantation & Plasticity|January 1, 1992
Behavioral effects of gangliosides: anatomical considerationsD F Emerich
Expert Opinion on Biological Therapy|December 1, 2001
Neuroprotective possibilities for Huntington's diseaseD F Emerich
JAMA|December 22, 1999
Cholinergic markers in Alzheimer diseaseR T Bartus, D F Emerich
Brain Research|September 17, 1990
Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64AD F Emerich, T J Walsh
Brain Research|May 28, 1990
Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicineD F Emerich, T J Walsh
Toxicology|April 1, 1988
The hippocampus as a common target of neurotoxic agentsT J Walsh, D F Emerich
Pageof 11

Showing results (1-10 of 103) with videos related to

Sort By:
Pageof 11
Cell Transplantation|July 4, 2002
Cell transplantation for Parkinson's diseaseD F Emerich
Trends in Neurosciences|June 6, 2000
Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing?D F Emerich
Cell Transplantation|September 5, 2017
Article Commentary: Cell Transplantation for Parkinson's DiseaseD F Emerich
Cell Transplantation|March 4, 2000
Encapsulated CNTF-producing cells for Huntington's diseaseD F Emerich
Journal of Neural Transplantation & Plasticity|January 1, 1992
Behavioral effects of gangliosides: anatomical considerationsD F Emerich
Expert Opinion on Biological Therapy|December 1, 2001
Neuroprotective possibilities for Huntington's diseaseD F Emerich
JAMA|December 22, 1999
Cholinergic markers in Alzheimer diseaseR T Bartus, D F Emerich
Brain Research|September 17, 1990
Ganglioside AGF2 promotes task-specific recovery and attenuates the cholinergic hypofunction induced by AF64AD F Emerich, T J Walsh
Brain Research|May 28, 1990
Cholinergic cell loss and cognitive impairments following intraventricular or intradentate injection of colchicineD F Emerich, T J Walsh
Toxicology|April 1, 1988
The hippocampus as a common target of neurotoxic agentsT J Walsh, D F Emerich
Pageof 11